CRH Medical Corp.

CRH-T

Analysis and Opinions about CRH-T

Signal
Opinion
Expert
TOP PICK
TOP PICK
August 25, 2015

The best small-cap company in Canada that he can recommend. Great management team. 9X 2016 earnings. 31% ROE. He is very comfortable in saying that in 5 years it will be a $25 stock.

The best small-cap company in Canada that he can recommend. Great management team. 9X 2016 earnings. 31% ROE. He is very comfortable in saying that in 5 years it will be a $25 stock.

Jason Donville
President & CEO, Donville Kent Asset Management
Price
$3.930
Owned
Yes
BUY WEAKNESS
BUY WEAKNESS
August 19, 2015

Continue to execute along the lines they said they were going to do. Had a very steady growing small business going back to December, and then they made an acquisition of anaesthesiology clinics and the stock really shot up. Just made another announcement today. Valuation tends to get stretched at times, but when it comes back it is one you can buy because they are probably going to continue to do acquisitions.

Continue to execute along the lines they said they were going to do. Had a very steady growing small business going back to December, and then they made an acquisition of anaesthesiology clinics and the stock really shot up. Just made another announcement today. Valuation tends to get stretched at times, but when it comes back it is one you can buy because they are probably going to continue to do acquisitions.

Bruce Campbell (2)
President & Portfolio Manager, Stone Castle Investment Management Inc.
Price
$4.560
Owned
Unknown
TOP PICK
TOP PICK
June 30, 2015

This is the medical stock that he is the most comfortable with as being a long-term compounder. They do colonoscopy clinics for early detection of cancer. Based in Vancouver. Good management team. Only trading at about 10 or 11 times 2016 earnings. 35% ROE.

This is the medical stock that he is the most comfortable with as being a long-term compounder. They do colonoscopy clinics for early detection of cancer. Based in Vancouver. Good management team. Only trading at about 10 or 11 times 2016 earnings. 35% ROE.

Jason Donville
President & CEO, Donville Kent Asset Management
Price
$4.740
Owned
Yes
COMMENT
COMMENT
June 30, 2015

This is widely liked. He likes the smaller healthcare companies and owns quite a few.

This is widely liked. He likes the smaller healthcare companies and owns quite a few.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$4.740
Owned
No
TOP PICK
TOP PICK
June 19, 2015

In terms of management, they are a little more conservative than some of the others. They were in the haemorrhoid business, but do a lot of anaesthesia for colonoscopies, etc, and that business has been growing very rapidly. Made a transformative acquisition at the end of last year, and are on the cusp of probably making a couple more over the next 6 months or so. Recent quarter was very strong and expects Q2 to be strong as well.

In terms of management, they are a little more conservative than some of the others. They were in the haemorrhoid business, but do a lot of anaesthesia for colonoscopies, etc, and that business has been growing very rapidly. Made a transformative acquisition at the end of last year, and are on the cusp of probably making a couple more over the next 6 months or so. Recent quarter was very strong and expects Q2 to be strong as well.

Peter Imhof
Vice President & Portfolio Manager, AGF Investments Inc
Price
$4.110
Owned
Yes
TOP PICK
TOP PICK
May 6, 2015

Had a big acquisition and we have now seen a quarter, which only represents 20% of their year. The quarter was clean. Good management team. Valuation is still reasonable. In a years time this can be a $5 or better stock.

Had a big acquisition and we have now seen a quarter, which only represents 20% of their year. The quarter was clean. Good management team. Valuation is still reasonable. In a years time this can be a $5 or better stock.

Jason Donville
President & CEO, Donville Kent Asset Management
Price
$3.330
Owned
Yes
BUY WEAKNESS
BUY WEAKNESS
May 1, 2015

(Market Call Minute.) A growth by acquisition story. Has doubled in the last 6 months.

(Market Call Minute.) A growth by acquisition story. Has doubled in the last 6 months.

Bruce Campbell (1)
President, Campbell and Lee InvMngmnt
Price
$3.480
Owned
No
COMMENT
COMMENT
April 8, 2015

A very interesting business. Their initial business was a solution for hemorrhoids. They made a transformational acquisition a few months ago of anaesthesiology services, specifically in the gastrointestinal area. They are seeing growth from an acquisition standpoint, but also from an organic standpoint now.

A very interesting business. Their initial business was a solution for hemorrhoids. They made a transformational acquisition a few months ago of anaesthesiology services, specifically in the gastrointestinal area. They are seeing growth from an acquisition standpoint, but also from an organic standpoint now.

Bruce Campbell (2)
President & Portfolio Manager, Stone Castle Investment Management Inc.
Price
$3.500
Owned
Yes
BUY
BUY
February 23, 2015

Hemorrhoid business. Acquisition they made is quite accretive. People are just becoming aware of this story. A high margin business.

CRH Medical Corp. (CRH-T)
February 23, 2015

Hemorrhoid business. Acquisition they made is quite accretive. People are just becoming aware of this story. A high margin business.

Peter Imhof
Vice President & Portfolio Manager, AGF Investments Inc
Price
$3.800
Owned
Unknown
HOLD
HOLD
February 5, 2015

This is getting ahead of itself. Likes the company and thinks the management team is great, but he needs to see more details before he could add more capital. He knows there are more acquisitions coming in after that, but put the current one to bed. If you are going to grow through acquisitions you have to show that you can acquire intelligently and integrate the acquisitions. Considers this as a “strong hold”.

CRH Medical Corp. (CRH-T)
February 5, 2015

This is getting ahead of itself. Likes the company and thinks the management team is great, but he needs to see more details before he could add more capital. He knows there are more acquisitions coming in after that, but put the current one to bed. If you are going to grow through acquisitions you have to show that you can acquire intelligently and integrate the acquisitions. Considers this as a “strong hold”.

Jason Donville
President & CEO, Donville Kent Asset Management
Price
$2.510
Owned
Yes
COMMENT
COMMENT
January 14, 2015

CRH Medical (CRH-T) or Merus Labs (MSL-T)? These are not really comparable to one another. This is the one that looks very interesting. Just made an acquisition at the beginning of December, and the stock had a big run. It looks like they could produce some really high numbers. If he were buying one or the other, it would probably be this one.

CRH Medical Corp. (CRH-T)
January 14, 2015

CRH Medical (CRH-T) or Merus Labs (MSL-T)? These are not really comparable to one another. This is the one that looks very interesting. Just made an acquisition at the beginning of December, and the stock had a big run. It looks like they could produce some really high numbers. If he were buying one or the other, it would probably be this one.

Bruce Campbell (2)
President & Portfolio Manager, Stone Castle Investment Management Inc.
Price
$2.040
Owned
No
TOP PICK
TOP PICK
December 24, 2014

A little company based in Vancouver that just had a transformational US acquisition. They are in the hemorrhoid business with clinics where people go in for procedures. This is one of those companies that is off the radar screen. His sense is that this is a $2.50 stock in a year’s time.

CRH Medical Corp. (CRH-T)
December 24, 2014

A little company based in Vancouver that just had a transformational US acquisition. They are in the hemorrhoid business with clinics where people go in for procedures. This is one of those companies that is off the radar screen. His sense is that this is a $2.50 stock in a year’s time.

Jason Donville
President & CEO, Donville Kent Asset Management
Price
$1.700
Owned
Yes
BUY
BUY
July 14, 2009
Small medical products company with primarily US operations and involved in haemorrhoid banding. Have their own clinics where they treat patients and also sell their product direct to physicians. Excellent company. Very early in rolling out their product so there is bound to be volatility. Good treat it as a trading stock.
Small medical products company with primarily US operations and involved in haemorrhoid banding. Have their own clinics where they treat patients and also sell their product direct to physicians. Excellent company. Very early in rolling out their product so there is bound to be volatility. Good treat it as a trading stock.
Karl Berger
Partner, Toron Investment Management
Price
$1.630
Owned
No
Showing 76 to 88 of 88 entries